Results
|
|
17301.
|
|
|
|
17302.
|
|
|
|
17303.
|
A phase I dose-escalation trial of trastuzumab and alvespimycin hydrochloride (KOS-1022; 17 DMAG) in the treatment of advanced solid tumors. [electronic resource] by
- Jhaveri, Komal
- Miller, Kathy
- Rosen, Lee
- Schneider, Bryan
- Chap, Linnea
- Hannah, Alison
- Zhong, Ziyang
- Ma, Weining
- Hudis, Clifford
- Modi, Shanu
Producer: 20130322
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18
Availability: No items available.
|
|
|
17304.
|
|
|
|
17305.
|
|
|
|
17306.
|
|
|
|
17307.
|
|
|
|
17308.
|
|
|
|
17309.
|
|
|
|
17310.
|
|
|
|
17311.
|
|
|
|
17312.
|
|
|
|
17313.
|
|
|
|
17314.
|
|
|
|
17315.
|
|
|
|
17316.
|
|
|
|
17317.
|
CD31 angiogenesis and combined expression of HIF-1α and HIF-2α are prognostic in primary clear-cell renal cell carcinoma (CC-RCC), but HIFα transcriptional products are not: implications for antiangiogenic trials and HIFα biomarker studies in primary CC-RCC. [electronic resource] by
- Biswas, Swethajit
- Charlesworth, Philip J S
- Turner, Gareth D H
- Leek, Russell
- Thamboo, Paul T
- Campo, Leticia
- Turley, Helen
- Dildey, Petra
- Protheroe, Andrew
- Cranston, David
- Gatter, Kevin C
- Pezzella, Francesco
- Harris, Adrian L
Producer: 20121031
In:
Carcinogenesis vol. 33
Availability: No items available.
|
|
|
17318.
|
|
|
|
17319.
|
|
|
|
17320.
|
|